Last week we were excited to announce our latest clinical results in Parkinson's Disease, published in the Journal of Neural Transmission in August!
Read more here: https://t.co/hd7G05JUbD
#parkinsonsdisease#digitalbiomarkers#Neurology
In @parkinsonstory, Marisa Wexler, MS, discusses a study published in the Journal of Neural Transmission that highlights the potential of our technology to serve as an adjunct tool for the clinical assessment of Parkinson’s: https://t.co/TNfaRQkXxR #PD#Neurology#biomarkers
Employee Spotlight 💡Meet Assaf Ben Shimon, Senior Software Engineer. He says NeuraLight is full of top performers in their fields & the talent among his colleagues stimulates his learning and growth! Learn more about our openings here: https://t.co/J3eYCS7FF3 #NeuraLighters
It's been a great week at the MDS Congress in Copenhagen for the NeuraLight team! We were thrilled to present our latest research in #Parkinsonsdisease. Interested to learn more about Oculometric #digitalbiomarkers? Drop us a note!
@paulg Hi Paul, here at NeuraLight we're an eye-tracking based digital health company working in ALS right now! We'd love to chat about how our existing tech could be applied to this problem. Our Chief Commercial Officer, @VivianDeWoskin is SF-bay based as well
Employee Spotlight 💡Meet Rachel Shafner our Finance & Operations Manager. We have Rachel to thank for finalizing our budget and ensuring long term financial stability! Learn more about our openings here: https://t.co/J3eYCS8duB #DigitalHealth#NeuraLighters
Employee Spotlight 💡Meet Anastasia, our Clinical Assistant! She joined the team to make an impact for patients with neurological disorders. Learn more about our openings here: https://t.co/J3eYCS8duB #AI#NeuraLighters
It's here! Will you be in Boston for the Digital Biomarkers & Clinical Measures in Neurology Summit this week? Join the NeuraLight team for our talk on Wednesday at 4:10pm ET, or stop by our booth anytime during the week!
This June's issue of @NatureBiotech featured commentary from NeuraLight's Chief Innovation Officer Rivka Kreitman on novel approaches to diagnosing & monitoring ALS.
Check out the full article here: https://t.co/fUlFGvB5I2
Employee Spotlight 💡Meet Hillel Rosensweig, our Software Engineer! He joined NeuraLight because of the benefits our technology could bring to the millions of people impacted by neurological disorders. Learn more about our openings here: https://t.co/J3eYCS8duB #AI#NeuraLighters
Employee Spotlight💡Meet Tali Band, our Medical Researcher! Tali is currently working on making theoretical medical information more accessible across the technological teams. Learn more about our openings here: https://t.co/J3eYCS7FF3
#AI#DigitalHealth#NeuraLighters
Employee Spotlight💡Meet Software Developer Naama Yochai! Naama joined our team because she was drawn to our mission and wanted to make a positive impact. Learn about open positions here: https://t.co/J3eYCS7FF3 #AI#DigitalHealth#NeuraLighters
The results are in 🏆! Global Health and Pharma named us a winner of their #biotechnology Awards. We were named the Most Innovative AI-Driven Neurology platform and could not be more excited to continue innovating! 🧠 https://t.co/o5nJD0R8dB
ICYMI: A recently published clinical study led by world-renowned Professor Vivian E Drory used our tech to establish a significant correlation between oculometric data & clinical assessment in ALS patients. Read about our #tech supporting #ALS assessment: https://t.co/mTAt2CX77u
Employee Spotlight💡Meet Eran Harpaz, a Senior Software Engineer. The hardest problem he’s recently solved was capturing eye movements from a standard webcam in any room and condition. Learn more about our openings here: https://t.co/J3eYCS7FF3
#AI#NeuraLighters#DigitalHealth
In a byline for @DDWJournal’s Spring Issue, our CIO Rivka Kreitman discusses recent advances in Alzheimer’s drug development and how digital biomarkers can fuel the future of novel neurodegenerative therapy discovery. https://t.co/LwrM3KLD5o
Our new CCO @VivianDeWoskin shares more about why she joined our team, her connection to our mission, and more in a new Q&A – check it out here: https://t.co/CNqI4rkApC 🌟 #CCO#Commercialization#Biotech#Neurology
.@NewMktsAdvisors’ Stephen Wunker sat down with @MichaBreakstone to discuss the current impediments to ALS-focused clinical trials, and how #DigitalBiomarkers can support the advancement of neurodegenerative disease-modifying therapies. #Neurology#Biotech https://t.co/hPTjSuUYjw
Help us welcome @VivianDeWoskin to NeuraLight as she embarks on her first days as our new Chief Commercial Officer. Joining us from Komodo Health, Vivian will be invaluable in advancing partnerships with industry and academic partners. #NewHire#Biotech https://t.co/zjCTF5Jg6E